Literature DB >> 19089994

Overexpression of delta Np63 in a human nasopharyngeal carcinoma cell line downregulates CKIs and enhances cell proliferation.

Chi-Tai Chiang1, Wing-Keung Chu, Shu-Er Chow, Jan-Kan Chen.   

Abstract

p63 belongs to a member of the tumor suppressor protein p53 family. Due to alternative promoter usage, two types of p63 proteins are produced. The DeltaNp63 isoform lacks the N-terminal transactivation domain and is thought to antagonize TAp63 and p53 in target gene regulation. DeltaNp63 has been found to be overexpressed in numerous human squamous cell carcinomas, including nasopharyngeal carcinoma (NPC). However, the role of DeltaNp63 overexpression in NPC pathogenesis has not been clear. In this study, we use a DeltaNp63 overexpressing human NPC cell line (NPC-076) to explore the possible roles of DeltaNp63 in cell proliferation and cell-cycle regulation. We found that the proliferation of NPC-076 cell is greatly suppressed when the overexpressed DeltaNp63 is silenced by specific DeltaNp63 siRNA. Further studies show that DeltaNp63 silencing results in the upregulation of CKIs, including p27(kip1) and p57(kip2) in both mRNA and protein levels. Cell-cycle analysis shows that DeltaNp63 silencing also results in an increased G1 phase cell and apoptotic cell population. Our findings indicate that DeltaNp63 plays important roles in the regulation of NPC-076 cell-cycle progression, and may play a role in the maintenance of NPC-076 tumor cell phenotype. (c) 2008 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19089994     DOI: 10.1002/jcp.21656

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  12 in total

1.  ΔNp63α regulates keratinocyte proliferation by controlling PTEN expression and localization.

Authors:  M K Leonard; R Kommagani; V Payal; L D Mayo; H N Shamma; M P Kadakia
Journal:  Cell Death Differ       Date:  2011-06-03       Impact factor: 15.828

2.  Possible involvement of ΔNp63 downregulation in the invasion and metastasis of oral squamous cell carcinoma via induction of a mesenchymal phenotype.

Authors:  Yuichi Goto; Shintaro Kawano; Ryota Matsubara; Takahiro Kiyosue; Mitsuhiro Hirano; Teppei Jinno; Yasuyuki Maruse; Takeshi Toyoshima; Ryoji Kitamura; Hideaki Tanaka; Kazunari Oobu; Seiji Nakamura
Journal:  Clin Exp Metastasis       Date:  2013-12-06       Impact factor: 5.150

3.  DeltaNp63 overexpression, alone and in combination with other biomarkers, predicts the development of oral cancer in patients with leukoplakia.

Authors:  Pierre Saintigny; Adel K El-Naggar; Vali Papadimitrakopoulou; Hening Ren; You-Hong Fan; Lei Feng; J Jack Lee; Edward S Kim; Waun Ki Hong; Scott M Lippman; Li Mao
Journal:  Clin Cancer Res       Date:  2009-09-22       Impact factor: 12.531

4.  Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.

Authors:  George Vasmatzis; Sarah H Johnson; Ryan A Knudson; Rhett P Ketterling; Esteban Braggio; Rafael Fonseca; David S Viswanatha; Mark E Law; N Sertac Kip; Nazan Ozsan; Stefan K Grebe; Lori A Frederick; Bruce W Eckloff; E Aubrey Thompson; Marshall E Kadin; Dragana Milosevic; Julie C Porcher; Yan W Asmann; David I Smith; Irina V Kovtun; Stephen M Ansell; Ahmet Dogan; Andrew L Feldman
Journal:  Blood       Date:  2012-08-01       Impact factor: 22.113

Review 5.  p63 is a suppressor of tumorigenesis and metastasis interacting with mutant p53.

Authors:  G Melino
Journal:  Cell Death Differ       Date:  2011-07-15       Impact factor: 15.828

6.  Wilms' tumor gene 1 regulates p63 and promotes cell proliferation in squamous cell carcinoma of the head and neck.

Authors:  Xingru Li; Sofia Ottosson; Sihan Wang; Emma Jernberg; Linda Boldrup; Xiaolian Gu; Karin Nylander; Aihong Li
Journal:  BMC Cancer       Date:  2015-05-01       Impact factor: 4.430

7.  Vimentin regulates differentiation switch via modulation of keratin 14 levels and their expression together correlates with poor prognosis in oral cancer patients.

Authors:  Crismita Dmello; Sharada Sawant; Hunain Alam; Prakash Gangadaran; Saie Mogre; Richa Tiwari; Zinia D'Souza; Manish Narkar; Rahul Thorat; Komal Patil; Devendra Chaukar; Shubhada Kane; Milind Vaidya
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

8.  Loss of p63 and its microRNA-205 target results in enhanced cell migration and metastasis in prostate cancer.

Authors:  Paola Tucci; Massimiliano Agostini; Francesca Grespi; Elke K Markert; Alessandro Terrinoni; Karen H Vousden; Patricia A J Muller; Volker Dötsch; Sebastian Kehrloesser; Berna S Sayan; Giuseppe Giaccone; Scott W Lowe; Nozomi Takahashi; Peter Vandenabeele; Richard A Knight; Arnold J Levine; Gerry Melino
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-04       Impact factor: 11.205

9.  Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients.

Authors:  Dimitrios Krikelis; Mattheos Bobos; Georgia Karayannopoulou; Liliana Resiga; Sofia Chrysafi; Epaminontas Samantas; Dimitrios Andreopoulos; Vassilios Vassiliou; Elisabeta Ciuleanu; George Fountzilas
Journal:  BMC Clin Pathol       Date:  2013-01-29

10.  Differential targeting of the cyclin-dependent kinase inhibitor, p21CIP1/WAF1, by chelators with anti-proliferative activity in a range of tumor cell-types.

Authors:  Rayan S Moussa; Zaklina Kovacevic; Des R Richardson
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.